Where does Hyung Chun work?

Hyung Chun is MD, Investment Team at Foresite Capital.

What check size does Hyung Chun write?

Hyung Chun typically writes checks of $2M – $75M.

What boards does Hyung Chun sit on?

Hyung Chun holds tracked board seats at Indomo, Latigo Bio, Modal Therapeutics.

Where did Hyung Chun go to school?

Hyung Chun studied at The Johns Hopkins University School of Medicine (Doctor of Medicine (MD)); Harvard University (AB, Biochemical Sciences).

Hyung Chun

Investor

MD, Investment Team at Foresite Capital

New Haven, Connecticut

Writes $2M – $75M checks · typically $38.5M

Find your path to Hyung

489 people in our graph share verified history with Hyung — schools, employers, funds. One of them is your warm intro.

Adam ValkinunlockedHyung: together at Harvard University (1992–1995)

Hyung: together at Yale University School of Medicine

×7Hyung: together at Harvard University

×2Hyung: together at National Institutes of Health

About

Hyung Chun is a physician scientist who joined Foresite Capital in 2021, where he evaluates investment opportunities in private and public biotech companies. Before Foresite, he was a tenured faculty member at Yale School of Medicine, where he held roles including Co-Director of the Yale Cardiovascular Research Center, and remains an adjunct faculty member. He earned an A.B. in Biochemical Sciences from Harvard College and an M.D. from Johns Hopkins, and completed his residency and cardiovascular fellowship at Stanford.

Invests in

Biotech

Experience

Foresite CapitalPartnercurrent2021 — present
Stanford University School of MedicineAdjunct Professorcurrent2023 — present
Yale University School of MedicineAdjunct Associate Professorcurrent2022 — presentNew Haven, Connecticut, United States
Yale University School of MedicineAssociate Professor of Medicine and Pathology with Tenure2019 — 2022
Yale University School of MedicineCo-Director, Yale Cardiovascular Research Center2021
Yale University School of MedicineAssociate Professor of Medicine2015 — 2019
Yale University School of MedicineAssistant Professor2009 — 2015
Latigo Biotherapeutics, Inc.Board Membercurrent2022 — present
Odyssey TherapeuticsBoard Observer2021 — 2024
Stanford University School of MedicineChief Cardiology Fellow2008 — 2009
Stanford University School of MedicineCardiology Fellow2004 — 2009
Stanford University School of MedicineInternal Medicine Resident2002 — 2004
National Institutes of HealthHHMI/NIH Research Scholar1999 — 2001

Skills & more

Higher EducationTeaching2University TeachingResearch4Statistics3Science4Student AffairsMolecular Biology7Public Speaking1Curriculum DesignQualitative ResearchCurriculum Development

+6 more

Grant WritingCell BiologyTutoringClinical ResearchClinical TrialsMedical Education

Languages Korean

ABIM Cardiovascular Medicine — American Board of Internal Medicine

From Hyung's professional profile.

Investments

Board seats

IndomoLatigo BioModal Therapeutics

Per the firm's website.

Colleagues at Foresite Capital

Alex M. Azar II

Advisor at Foresite Capital

Amelia Stoj

CCO and Assistant General Counsel at Foresite Capital

Charmaine Villasin

Origination at EVP

Collin Yang-Wong

Principal at Foresite Capital

Cynthia Carpenter

Executive Associate at Foresite Capital

Darren Haggerty

Operations Investment Analyst at Foresite Capital

Deepak Atri

Principal at Foresite Capital

Deepak Atri, MD

Investor at Foresite Capital

Network1

Desmond Padhi

Operating Partner at Westlake Village BioPartners

Investors connected to Hyung in public investor directories — a warm-intro map.

Frequently asked questions

Who is Hyung Chun?: Hyung Chun is a physician scientist who joined Foresite Capital in 2021, where he evaluates investment opportunities in private and public biotech companies. Before Foresite, he was a tenured faculty member at Yale School of Medicine, where he held roles including Co-Director of the Yale Cardiovascular Research Center, and remains an adjunct faculty member. He earned an A.B. in Biochemical Sciences from Harvard College and an M.D. from Johns Hopkins, and completed his residency and cardiovascular fellowship at Stanford.
Where does Hyung Chun work?: Hyung Chun is MD, Investment Team at Foresite Capital.
What does Hyung Chun invest in?: Hyung Chun invests in Biotech.
What check size does Hyung Chun write?: Hyung Chun typically writes checks of $2M – $75M.
What boards does Hyung Chun sit on?: Hyung Chun holds tracked board seats at Indomo, Latigo Bio, Modal Therapeutics.
Where did Hyung Chun go to school?: Hyung Chun studied at The Johns Hopkins University School of Medicine (Doctor of Medicine (MD)); Harvard University (AB, Biochemical Sciences).

Same school

Also attended The Johns Hopkins University School of Medicine59

Hal PazInvestor at Khosla Ventures Rochelle WalenskyExecutive Partner at Flare Capital Partners Beth SeidenbergFounding Managing Director at Westlake Village BioPartners Stephen P. ZacharyManaging Partner at Sands Capital Ventures S.K. LeeExecutive Coach at Roble Ventures Eric HsuAnalyst, Private Equity at Sofinnova Ventures

+ 53 more

Also attended Harvard University2,000

Ron ConwayFounder of SV Angel Alfred LinPartner at Sequoia Capital Chris DixonFounder & Managing Partner of a16z crypto at Andreessen Horowitz Sarah TavelVenture Partner at Benchmark Danny RimerPartner at Index Ventures Laela SturdyManaging Partner at CapitalG

+ 1,994 more

Shared employers

Also worked at Yale University School of Medicine68

Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University Partners David Rosenthal, MDVenture Partner at AlleyCorp Alley (Welsh) OlshanskyAdvisor at Casdin Capital Sophie RobinsonSenior Associate at Cure Ventures Michael RechtChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures

+ 62 more

+ 169 more